Selection elimination of anti-insulin B cells prevents disease in type 1 diabetes-prone mice (22); targeting ASBCs may thus offer an effective alternative to broad immunosuppression for autoimmune disease prevention and treatment. The gene discussed is INS; the disease is type 1 diabetes mellitus.